The Financial Express6d
Zydus Lifesciences soars 3% on US FDA nod for manufacturing Apalutamide Tablets
Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...
Here's why Zydus Lifesciences share price popped 3% in trade on March 19
The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...
Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drug
The approval covers Apalutamide tablets of 60 mg strength, the company said in a regulatory filing. The drug will be ...
Zydus Life receives USFDA approval for manufacturing Apalutamide tablets, 60 mg
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Apalutamide tablets, 60 mg.
Zydus Lifesciences jumps 8% as USFDA approves Apalutamide tablets
Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...
Zydus Lifesciences share price gain on final USFDA approval for cancer drug
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...
EquityBulls6d
Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.
Zydus Lifesciences & Zydus Wellness Shares React To US FDA Approval For A Prostate Cancer Drug
On March 18, post-market hours, Zydus Lifesciences announced that it has received approval from the United States Food & Drug ...
IndiaInfoline6d
Zydus Lifesciences gets USFDA approval for apalutamide tablets
As per the IQVIA MAT January 2025 data, apalutamide tablets registered annual sales of $1099.80 million in the United States markets.